The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'

Annals of the Rheumatic Diseases

Volumn 74, Issue 6, 2015, Pages 1004-1010

  Van Tuyl, Lilian H D ^a   Hewlett, Sarah ^b   Sadlonova, Martina ^c   Davis, Bev ^d   Flurey, Caroline ^b   Hoogland, Wijnanda ^a   Kirwan, John ^e   Sanderson, Tessa ^b   Van Schaardenburg, Dirkjan ^f   Scholte Voshaar, Marieke ^a   Smolen, Josef ^c   Stamm, Tanja ^c   Boers, Maarten ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d BRISTOL ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f Jan Van Breemen Research Institute/Reade   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTHRALGIA; ARTICLE; AUSTRIA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DISEASE DURATION; FATIGUE; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; JOINT STIFFNESS; JOINT SWELLING; MALE; MOOD; NETHERLANDS; PERSONAL EXPERIENCE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; THEMATIC ANALYSIS; UNITED KINGDOM; ADAPTIVE BEHAVIOR; AGED; ATTITUDE TO HEALTH; INFORMATION PROCESSING; MIDDLE AGED; PSYCHOLOGY; QUALITATIVE RESEARCH; RETURN TO WORK; SEVERITY OF ILLNESS INDEX;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; REMISSION INDUCTION; RETURN TO WORK; SEVERITY OF ILLNESS INDEX;

EID: 84934956022     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204798     Document Type: Article

References (28)

1. Aletaha D, Landewe R, Karonitsch T, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008;67:1360-4.
2. Boers M, Tugwell P, Felson DT, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9.
3. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
4. Prevoo ML, Van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
5. Van der Heijde DM, van 't HM, van Riel PL, et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
6. Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
7. Maiden N, Capell HA, Madhok R, et al. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis 1999;58:525-9.
8. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
9. Pincus T, Chung C, Segurado OG, et al. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006;33:2146-52.
10. Sokka T, Hakkinen A, Krishnan E, et al. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 2004;63:494-7.
11. Minnock P, Kirwan J, Bresnihan B. Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1533-6.
12. Nicklin J, Cramp F, Kirwan J, et al. Collaboration with patients in the design of patient-reported outcome measures: Capturing the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:1552-8.
13. Wells G, Li T, Maxwell L, et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008;67:260-5.
14. Kirwan JR, Minnock P, Adebajo A, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007;34:1174-7.
15. Hewlett S, Carr M, Ryan S, et al. Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 2005;3:131-42.
16. Kirwan JR, Newman S, Tugwell PS, et al. Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol 2009;36:2071-6.
17. van Tuyl LH, Smolen JS, Wells GA, et al. Patient perspective on remission in rheumatoid arthritis. J Rheumatol 2011;38:1735-8.
18. Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-37.
19. rd edn. Sage Publications Inc., 2000.
20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psych 2006;3:77-101.
22. Sanderson T, Hewlett S, Flurey C, et al. The impact triad (incorporating severity, importance and self-management) as a method of enhancing the measurement of the personal life impact of rheumatic diseases. J Rheumatol 2011;38:191-4.
23. Fries JF, Spitz PW, Williams CA, et al. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-30.
24. Kristiansen TM, Primdahl J, Antoft R, et al. It means everything: continuing normality of everyday life for people with rheumatoid arthritis in early remission. Musculoskeletal Care 2012;10:162-70.
25. Gossec L, Dougados M, Rincheval N, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 2009;68:1680-5.
26. Sanderson T, Calnan M, Morris M, et al. Shifting normalities: interactions of changing conceptions of a normal life and the normalisation of symptoms in rheumatoid arthritis. Sociol Health Illn 2011;33:618-33.
27. Masri KR, Shaver TS, Shahouri SH, et al. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. J Rheumatol 2012;39:1139-45.
28. van Tuyl LH, Boers M. Patient's global assessment of disease activity: what are we measuring? Arthritis Rheum 2012;64:2811-3.